共 4 条
Interleukin-13 inhibition by tralokinumab reduces inducible T-cell costimulator-positive innate lymphoid cells in skin lesions of atopic dermatitis
被引:0
|作者:
Kogame, Toshiaki
[1
]
Yonekura, Satoru
[1
]
Lovato, Paola
[2
]
Hirata, Masahiro
[3
]
Takimoto-ito, Riko
[1
]
Takegami, Tomoya
[1
]
Komatsu-Fujii, Takayoshi
[1
]
Kambe, Naotomo
[1
]
Nomura, Takashi
[1
]
Ropke, Mads A.
[2
]
Kabashima, Kenji
[1
]
机构:
[1] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan
[2] LEO Pharm A S, Ballerup, Denmark
[3] Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto, Japan
关键词:
D O I:
10.1093/bjd/ljac008
中图分类号:
R75 [皮肤病学与性病学];
学科分类号:
100206 ;
摘要:
Despite the low frequency of skin ILCs and the limited number of samples analyzed in this study, our data indicate that ICOS+ ILCs express IL-13Ra1 and that the density of ICOS+ ILCs decreased four weeks after initiation of treatment with tralokinumab.
引用
收藏
页码:146 / 148
页数:3
相关论文